Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 14 of 14 for “"Cabergoline"”.
-
Evaluation of Dopaminergic and Antidopaminergic Agents for Use in Equine Metabolic Physiology
… to assess the long-term effects of repeated cabergoline injections (every 10 days for a total of seven injections) on prolactin and α-melanocyte stimulating hormone concentrations in insulin insensitive mares. Additionally, the experiment also evaluated the use of cabergoline for improving …
-
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
… frequent pituitary adenomas. The treatment with cabergoline, the most common dopamine agonist used, is associated with side effects such as nausea, vomiting, dizziness, headaches, movement disorders and fatigue. There is some additional evidence from case reports and small studies that some …
-
Υποδοχείς σωματοστατίνης και ντοπαμίνης: συσχέτιση με το σύστημα mtor στη ρύθμιση του κυτταρικού πολλαπλασιασμού σε καρκινοειδές πνεύμονα και καρκίνου του επινεφριδίου
… for NETs. No data are available about the use of Cabergoline in the treatment of these tumors. The aim of our study is to evaluate the effect of the combined treatment of Octreotide and Cabergoline in combination with mTOR inhibition in the only existing in vitro model of typical LCs: H727 cell …
-
Implications of dopamine D3 receptor for glaucoma: in-silico and in-vivo studies
… target for ocular hypotensive drugs. Cabergoline, bromocriptine, cianergoline and legotrile, classical D2 receptor agonists, have been shown to decrease intraocular pressure. D3 receptor belongs to the D2 class of dopaminergic receptors, along with D2 and D4 receptor. It shares high …
-
Evaluation of a Role for Prolactin in the Recrudescense of Ovarian Activity in Seasonally Anovulatory Mares
… in mares. The first experiment was based on cabergoline administration to seasonally anovulatory mares to prevent the seasonal rise in endogenous plasma prolactin to assess whether reduced prolactin altered onset of ovarian activity or first ovulation. Although prolactin concentrations were …
-
Η φαρμακογενής υπερπρολακτιναιμία σε σχιζοφρενικούς αρρώστους: ελεγχόμενη μελέτη της ντοπαμινικής υπόθεσης
… investigate the effects of the dopamine agonistcabergoline on sexual dysfunction in clinically stable patients with schizophrenia (DSM-IV, AP194) and hyperprolactinemia (PRL>20 ng/ml for men and PRL>25 ng/ml for women), wellmaintained on a PRL- raising antipsychotic (risperidone, amisulpride or …
-
MOLECULAR MECHANISMS UNDERLYING CLINICAL BEHAVIOR OF NEUROENDOCRINE TUMORS: STUDY OF NEW POSSIBLE BIOMARKERS PREDICTABLE OF PHARMACOLOGICAL RESISTANCE AND TARGETS
… action of DAs. In accordance, it was showed that cabergoline improved everolimus efficacy by blocking AKT upstream reactivation in NF-PitNETs and tumoral lactotrophs. In fact, the combined treatment with cabergoline strongly reduced the increase of AKT activity, correlating with its antimitotic …
-
Physiological and Endocrine Factors Contributing to Acyclicity in the Captive Female African Elephant (Loxodonta africana)
… normal ovarian cycles. Oral administrations of Cabergoline (dopamine agonist; n=4) and domperidone (dopamine antagonist; n=4) were studied as possible treatments for hyperprolactinemia or prolactin deficiency, respectively. Prolactin synthesis can be regulated with either a dopamine agonist or …
-
Makroprolaktinomų diagnostika ir gydymo strategijos: literatūros apžvalga ir klinikinio atvejo analizė /
… precipitation optimizes diagnostic accuracy. Cabergoline is prescribed as the first-line treatment for macroprolactinomas, which normalizes prolactin levels and significantly reduces tumor size. Drug intolerance, resistance may require dose escalation, switching to other dopamine agonists or …
-
Brain mechanisms underlying option generation for behaviour
… two pharmacological studies of dopamine agonist (cabergoline) and antagonist (haloperidol). These provided the first direct evidence that dopamine modulates option generation for behaviour in humans, specifically in the aspects of fluency (generating many options) and uniqueness (how different …
-
Η επίδραση της συμμόρφωσης στη θεραπευτική αποτελεσματικότητα αναλόγων σωματοστατίνης σε ασθενείς με μεγαλακρία
… bromocriptine then quinagolide and last cabergoline), and since 1990 with the administration of somatostatin analogs (octreotide - lanreotide and recently pasreotide). Finally, since 2003, in the medication treatment of acromegaly, has been added the administration of pegvisomat, a growth …
-
The Role of Prolactin/Prolactin Receptor System in Nociceptor Sensitization and Pain in Females
… lowering circulating PRL by dopamine D2 agonist, cabergoline, rescued OIH selectively in females. Thus, our studies demonstrate that circulating PRL/PRLR system is a female-selective mechanism of OIH. Opioids are also strongly associated with the development of medication overuse headache (MOH). …
-
Η λήψη φαρμακευτικής αγωγής στο θηλασμό ως παράγοντας για τη διακοπή του: μία προοπτική και περιγραφική μελέτη στην Ελλάδα
… tramadole (12.5%), ergometrine (60.3%) and cabergoline (0.2%) were also administered to mothers, which according to Lactmed should be used with caution or avoided during lactation. Notably, it was observed widespread administration of metronidazole (24.1%), a medicine surrounded by …
-
Untersuchung der fibrotischen Effekte des Dopaminagonisten Cabergolin an Herzklappen des Schweins
Ziel der vorliegenden Arbeit war es, die Mechanismen der Nebenwirkungen von Carbergolin und anderen Vertretern der Ergoline zu untersuchen, die zu fibrotischen Veränderungen der Herzklappen führen. Herzklappenfibrosen treten insbesondere bei der Therapie von M. Parkinson auf und führen zu …